Newsletter June 2021

Events

Fujifilm Partnership Kickoff Event

Please join us for a virtual event with Fujifilm Open Innovation Hub to learn about how Fujifilm can provide solutions that further accelerate your biotech innovation! The head of Fujifilm Open Innovation Hub of Santa Clara, Aki Machida, will moderate the webinar which highlights Fujifilm's life science products and technologies. The webinar will be followed by a fireside chat, during which audience members will be invited to participate in a Q&A with our panelists. Register today!

June 23, 2021 12:00-1:00 PM PST

News

MBC BioLabs is Delighted to Welcome NanoTemper as its Newest Partner

MBC BioLabs is thrilled to announce NanoTemper as its newest partner! A Tycho System is now available at the MBC BioLabs San Carlos Industrial facility. Tycho provides a myriad of data on the quality of your protein. Measure presence, purity, concentration, functionality and similarity — in a single experiment! Tycho verifies protein quality by looking at the structural integrity (or foldedness) of a protein. As a thermal ramp is applied, the changes in the intrinsic fluorescence, detected at both 350 nm and 330 nm, from tryptophan and tyrosine residues in the protein are measured. These changes in fluorescence signal indicate transitions in the folding state of a protein. The temperature at which a transition occurs is called the inflection temperature (Ti). The fluorescence is recorded during the thermal run, plotted as ratio and used to calculate Ti. Its initial value along with the change in signal over the run (Δ ratio) is also recorded.

New Companies

Syncopation Life Sciences

Syncopation Life Sciences is an adoptive cell therapy company recently launched by founders from Stanford University in partnership with Samsara BioCapital. They are developing novel, CAR T-based technologies and programs to address important drivers of resistance to first-generation cell therapies. The company is based in the San Francisco Bay Area, where we are building a team of talented scientists and drug developers to bring a new generation of cell therapies to the clinic.

Origen Hydrogen

Origen Hydrogen is commercializing a breakthrough AEM electrolyzer technology to produce green hydrogen.  Green hydrogen can play a versatile role in reducing CO2 emissions for steel and fertilizer production, long-term energy storage, and a fuel for semi-trucks, ships and airplanes. By eliminating the requirement for expensive metal components and catalysts due to a non-acidic environment, Origen enables a credible path to $1/kg green hydrogen. Their team has industry and R&D experience from BP, Stanford, Air Liquide NREL, Linde, GM, FuelCell Energy and MIT.